42 related articles for article (PubMed ID: 15953360)
21. Megakaryoblastic leukemia 1, a potent transcriptional coactivator for serum response factor (SRF), is required for serum induction of SRF target genes.
Cen B; Selvaraj A; Burgess RC; Hitzler JK; Ma Z; Morris SW; Prywes R
Mol Cell Biol; 2003 Sep; 23(18):6597-608. PubMed ID: 12944485
[TBL] [Abstract][Full Text] [Related]
22. The RhoA/Rho kinase pathway regulates nuclear localization of serum response factor.
Liu HW; Halayko AJ; Fernandes DJ; Harmon GS; McCauley JA; Kocieniewski P; McConville J; Fu Y; Forsythe SM; Kogut P; Bellam S; Dowell M; Churchill J; Lesso H; Kassiri K; Mitchell RW; Hershenson MB; Camoretti-Mercado B; Solway J
Am J Respir Cell Mol Biol; 2003 Jul; 29(1):39-47. PubMed ID: 12600823
[TBL] [Abstract][Full Text] [Related]
23. RhoA as a mediator of clinically relevant androgen action in prostate cancer cells.
Schmidt LJ; Duncan K; Yadav N; Regan KM; Verone AR; Lohse CM; Pop EA; Attwood K; Wilding G; Mohler JL; Sebo TJ; Tindall DJ; Heemers HV
Mol Endocrinol; 2012 May; 26(5):716-35. PubMed ID: 22456196
[TBL] [Abstract][Full Text] [Related]
24. Tech: a RhoA GEF selectively expressed in hippocampal and cortical neurons.
Marx R; Henderson J; Wang J; Baraban JM
J Neurochem; 2005 Feb; 92(4):850-8. PubMed ID: 15686487
[TBL] [Abstract][Full Text] [Related]
25. Actin dynamics control SRF activity by regulation of its coactivator MAL.
Miralles F; Posern G; Zaromytidou AI; Treisman R
Cell; 2003 May; 113(3):329-42. PubMed ID: 12732141
[TBL] [Abstract][Full Text] [Related]
26. Mechanotransduction: from the cell surface to the nucleus via RhoA.
Burridge K; Monaghan-Benson E; Graham DM
Philos Trans R Soc Lond B Biol Sci; 2019 Aug; 374(1779):20180229. PubMed ID: 31431179
[TBL] [Abstract][Full Text] [Related]
27. SRF in Neurochemistry: Overview of Recent Advances in Research on the Nervous System.
Tabuchi A; Ihara D
Neurochem Res; 2022 Sep; 47(9):2545-2557. PubMed ID: 35668335
[TBL] [Abstract][Full Text] [Related]
28. Molecular Mechanisms of Leukocyte Migration and Its Potential Targeting-Lessons Learned From MKL1/SRF-Related Primary Immunodeficiency Diseases.
Sprenkeler EGG; Guenther C; Faisal I; Kuijpers TW; Fagerholm SC
Front Immunol; 2021; 12():615477. PubMed ID: 33692789
[TBL] [Abstract][Full Text] [Related]
29. Cytokine-induced nuclear translocation of signaling proteins and their analysis using the inducible translocation trap system.
Saint Fleur S; Fujii H
Cytokine; 2008 Mar; 41(3):187-97. PubMed ID: 18203617
[TBL] [Abstract][Full Text] [Related]
30. RBM15 Functions in Blood Diseases.
Hu M; Yang Y; Ji Z; Luo J
Curr Cancer Drug Targets; 2016; 16(7):579-85. PubMed ID: 26758534
[TBL] [Abstract][Full Text] [Related]
31. Nuclear translocation of the SRF co-activator MAL in cortical neurons: role of RhoA signalling.
Tabuchi A; Estevez M; Henderson JA; Marx R; Shiota J; Nakano H; Baraban JM
J Neurochem; 2005 Jul; 94(1):169-80. PubMed ID: 15953360
[TBL] [Abstract][Full Text] [Related]
32. Myocardin/MKL family of SRF coactivators: key regulators of immediate early and muscle specific gene expression.
Cen B; Selvaraj A; Prywes R
J Cell Biochem; 2004 Sep; 93(1):74-82. PubMed ID: 15352164
[TBL] [Abstract][Full Text] [Related]
33. A nuclear MAL-function links Rho to SRF.
Settleman J
Mol Cell; 2003 May; 11(5):1121-3. PubMed ID: 12769835
[TBL] [Abstract][Full Text] [Related]
34.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
35.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
36.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
37.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
38.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
39.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
